Learn / DFTX
NASDAQ: DFTX
Definium Therapeutics (DFTX) stock, explained like you're 5
Definium Therapeutics trades on the Nasdaq under the ticker DFTX. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 5 billion dollars.
- Ticker
- DFTX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medicinal Chemicals and Botanical Products
- Size
- Mid cap, about 5 billion dollars
Is Definium Therapeutics a small, medium or large cap company?
No. Definium Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Definium Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves DFTX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- DFTX Stock Rallies As Psychedelic Drug Delivers Positive Anxiety Trial Results Retail Says DT120 Could ‘Disrupt The Market’ (Stocktwits)
- Definium Therapeutics Announces New Employee Inducement Grants (Business Wire)
- Definium Therapeutics: Outstanding Phase III Data De Risks Pipeline, But Patience Required Ahead Of 2027 (Seeking Alpha)
- DFTX Nov 2026 38.000 put (DFTX261120P00038000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- The Technical Signals Behind (DFTX) That Institutions Follow (Stock Traders Daily)
Follow DFTX in your daily brief
Each trading day at 5 PM ET we post what happened to Definium Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow DFTX
Questions about Definium Therapeutics stock
What does Definium Therapeutics do?
Definium Therapeutics trades on the Nasdaq under the ticker DFTX. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 5 billion dollars.
What is the ticker symbol for Definium Therapeutics?
Definium Therapeutics trades under the ticker DFTX on the Nasdaq.
What is Definium Therapeutics's market cap?
Definium Therapeutics is a mid cap stock with a market cap of about 5 billion dollars.
How does Definium Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves DFTX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow DFTX stock every day?
Add DFTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.